Canopy Growth Corporation

TSX:WEED.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.72 +2.26%

+$0.03 today

Market cap
$323.72M
Beta
2.41
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $1.18High $3.28

Volume 1.16M

Average 2.07M

WEED.TO EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Canopy Growth CorporationTSX: WEED.TO

EBITDA · Q4 FY2025 · quarter ended Mar 2026

EBITDA remains negative

Q4 FY2025 EBITDA was -CA$18.82M, compared with -CA$194.32M a year earlier. Trailing-twelve-month EBITDA was -CA$63.48M.

Context

  • EBITDA amounted to 66.1% of revenue in FY2025, down 112.1 pp from a year earlier.
  • EBITDA grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 7 analysts of CA$50.62M (+126.9%) for the fiscal year ending Mar 2027, a step up from the +60.7% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$18.82M+59.1% QoQ
Last fiscal yearMar 2026
-CA$188.22M+60.7% YoY
LTMMar 2026
-CA$63.48M+86.8% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+90.3%+123.6%+33.3 pp
1 year+60.7%+126.9%+66.2 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

CAD · from the income statement

Latest · FY2025
(188.22M) CAD
Year-over-year change
+60.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How WEED.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +86.8% is the 3rd highest of 8, against a peer median of +45.8%.
  • EBITDA amounts to 20.4% of revenue for WEED.TO, versus a peer median of 23.1%.
WEED.TO Competitors
EBITDA for WEED.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TSND.TOTerrAscend Corp.LTM Mar 2026$60.46M USD+510.4%—23.1%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$49.15M CAD+45.8%—31.0%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$25.12M USD+96.0%+26.0%49.3%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$9.82M CAD-80.9%—3.1%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-$5.36M USD+48.2%—10.5%
EDT.TOSpectral Medical Inc.LTM Mar 2026-CA$35.21M CAD-81.6%—1275.3%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$40.84M CAD-681.4%—14.9%
WEED.TOCanopy Growth CorporationLTM Mar 2026-CA$63.48M CAD+86.8%—20.4%
Peer median (excluding WEED.TO) —+45.8%+26.0%23.1%

Competitors are the stored peer set for WEED.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue475.7M333.25M297.15M269M284.6M
Cost of Revenue653.93M431.64M216.26M189.48M214.93M
Gross Profit(143.6M)(98.38M)80.88M79.51M69.67M
Gross Margin-30.2%-29.5%27.2%29.6%24.5%
Research & Development32.26M21.72M4.61M2.74M0
Selling, General & Admin361.1M297.98M175.98M121.71M122.93M
Operating Expenses445.08M297.4M309.6M196.65M142.78M
Depreciation & Amortization110.94M80.03M53.18M43.12M36.47M
EBITDA(52.98M)(2.88B)(312.83M)(479.31M)(188.22M)
EBITDA Margin-11.1%-864.2%-105.3%-178.2%-66.1%
Operating Income(588.69M)(395.78M)(228.71M)(117.14M)(73.11M)
Operating Margin-123.8%-118.8%-77.0%-43.5%-25.7%
Interest Income6.6M24.28M16.24M8.82M10M
Interest Expense103.94M126.16M105.35M74.57M38.19M
Other Income / Expenses370.63M(2.69B)(242.64M)(479.85M)(189.78M)
Income Before Tax(267.86M)(3.09B)(471.36M)(597M)(262.89M)
Pre-Tax Margin-56.3%-926.1%-158.6%-221.9%-92.4%
Income Tax Expense(8.95M)(5.73M)12.33M7.14M23K
Net Income(310.04M)(3.28B)(657.27M)(598.12M)(262.91M)
Net Margin-65.2%-983.7%-221.2%-222.4%-92.4%
EPS (Basic)(0.81)(12.18)(8.79)(5.56)(0.76)
EPS (Diluted)(0.81)(12.18)(8.79)(5.56)(0.76)
Weighted Avg Shares396.1M271.61M74.79M107.55M345.53M
Weighted Avg Shares (Diluted)396.36M271.61M74.79M107.55M345.53M

Canopy Growth Corporation

TSX:WEED.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.